Fortune Sky is Your Go-to Source for the Latest Finance News, Covering Markets, Business, Industries and Internet.
⎯ 《 Fortune • Sky 》

List of All Articles with Tag 'nov'

European Stocks Lifted by Luxury as China Eases Travel Curbs
European Stocks Lifted by Luxury as China Eases Travel Curbs
European stocks extended gains into a second session, as China’s decision to relax travel curbs offered a lift
2023-08-10 15:55
Novo’s Blockbuster Obesity Drug Still Hit by US Bottlenecks
Novo’s Blockbuster Obesity Drug Still Hit by US Bottlenecks
Novo Nordisk A/S said the supply of its blockbuster obesity medicine Wegovy will continue to be restricted in
2023-08-10 14:53
Novo’s Value Surpasses Denmark GDP After Obesity Drug Boost
Novo’s Value Surpasses Denmark GDP After Obesity Drug Boost
Novo Nordisk A/S has just reached another milestone in its meteoric rise: the market value of the Danish
2023-08-09 19:54
PE firm KKR acquires $373 million portfolio of Synovus Bank's prime auto loans
PE firm KKR acquires $373 million portfolio of Synovus Bank's prime auto loans
Private equity giant KKR said on Tuesday it had acquired a $373 million portfolio of prime auto loans
2023-08-09 05:55
Weight-Loss Stocks Soar After Obesity-Drug Study Spurs Investor Frenzy
Weight-Loss Stocks Soar After Obesity-Drug Study Spurs Investor Frenzy
Wall Street’s enthusiasm for all things weight-loss related got a fresh boost Tuesday after results for a Novo
2023-08-09 01:47
Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows
Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows
Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the
2023-08-08 18:46
Bain, Cinven Weighs Sale of €10 Billion Drugmaker Stada
Bain, Cinven Weighs Sale of €10 Billion Drugmaker Stada
The private equity owners of Stada Arzneimittel AG are weighing options for the German drugmaker, including a possible
2023-08-03 00:23
Novartis Raises Outlook, Plans Buyback of Up to $15 Billion
Novartis Raises Outlook, Plans Buyback of Up to $15 Billion
Novartis AG raised its profit outlook and announced plans to buy back as much as $15 billion in
2023-07-18 13:57
Novartis raises outlook, maps out Sandoz spin-off
Novartis raises outlook, maps out Sandoz spin-off
By Ludwig Burger FRANKFURT (Reuters) -Novartis on Tuesday raised its full-year earnings guidance on strong drug sales and mapped out
2023-07-18 13:52
Lilly to Pay Up to $2 Billion for Obesity Startup Versanis
Lilly to Pay Up to $2 Billion for Obesity Startup Versanis
Eli Lilly & Co. will acquire closely held Versanis Bio, a startup developing a drug for obesity and
2023-07-14 23:27
Strong U.S. demand eases pressure on Novo to show weight-loss drug's health benefits
Strong U.S. demand eases pressure on Novo to show weight-loss drug's health benefits
By Maggie Fick LONDON Soaring U.S. demand for Novo Nordisk's weight-loss drug has reduced the pressure from investors
2023-07-14 13:22
Novo Weight Drugs Probed Over Reports of Suicidal Thoughts
Novo Weight Drugs Probed Over Reports of Suicidal Thoughts
Novo Nordisk A/S’s weight-loss medications are under investigation by the European Union’s drugs regulator after a small number
2023-07-10 20:17
«5678»